Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
New Oriental FY2025 Fourth Quarter Earnings Call - Board Commits at Least 50% of Net Income to Shareholders after $700M Buyback
New Oriental closed FY2025 with better-than-expected Q4 operating momentum, driven by new ventures, tourism and improved operating leverage, but management is dialing back near-term revenue expectatio...
- Q4 total net revenue excluding Easter buy private label and live streaming rose 18.7% year over year, management says, with new ventures cited as the main contributor.
- Non-GAAP operating margin excluding Easter buy reached 6.5% in Q4, a year over year improvement of about 410 basis points, credited to operating leverage and cost controls initiated since March.
- GAAP operating loss was $8.7 million in the quarter versus operating income of $10.5 million a year ago; non-GAAP operating income (ex-SBC, amortization and the kindergarten goodwill impairment) was $81.7 million, up 116.3% year over year.
- +12 more takeaways
LXP Industrial Trust Q2 2025 Earnings Call - Lease-up of 1,100,000 sq ft Greenville-Spartanburg development and leverage progress
LXP reported a quietly solid quarter, driven by the lease up of a 1.1 million square foot development in Greenville Spartanburg, steady same-store NOI growth, and deliberate deleveraging. Management t...
- Leased a 1,100,000 square foot development in Greenville Spartanburg to a U.S. subsidiary of a global logistics company, immediate occupancy, low TI, annual cash base rent roughly $6.0 million, cash rent commences August 1.
- Adjusted company FFO for Q2 was $0.16 per diluted common share, approximately $47.0 million, and 2025 adjusted company FFO guidance tightened to $0.62 to $0.64.
- Same-store NOI grew 4.7% in Q2, same-store portfolio was 98% leased at quarter end, and full-year same-store NOI growth guidance remains 3% to 4% assuming year-end same-store occupancy of 97% to 99%.
- +11 more takeaways
Standex International Fiscal Fourth Quarter 2025 Earnings Call - Company says FY2026 is an inflection year, targeting >$100M revenue lift driven by acquisitions, new products and fast-growth markets
Standex delivered a quarter that looks more like a strategic turning point than a routine report. Q4 revenue rose 23.2% to $222 million, driven almost entirely by acquisitions (23.4%), while organic r...
- Q4 revenue up 23.2% year over year to $222 million, but organic revenue fell 1.4%, with acquisitions contributing ~23.4% of the increase.
- Adjusted operating margin reached a record 20.6% in Q4, up 350 basis points year over year; management calls this the third consecutive quarter of record profit generation.
- Management expects fiscal 2026 to deliver more than $100 million of incremental revenue, driven by acquisitions, new products, and fast-growth end markets.
- +13 more takeaways
Option Care Health Q2 2025 Earnings Call - Raised 2025 Guidance After 15% Revenue Gain and Strong Cash Generation
Option Care Health posted a strong Q2, with revenue up 15.4% year over year and balanced mid teens growth across both acute and chronic portfolios. Management raised full year 2025 guidance, citing re...
- Revenue grew 15.4% year over year in Q2 2025, with mid teens expansion in both acute and chronic therapy portfolios.
- Management raised full year 2025 guidance to revenue of $5.50 billion to $5.65 billion, adjusted EBITDA $465 million to $475 million, and adjusted EPS $1.65 to $1.72.
- Gross profit was $269 million, up about 8% year over year, though gross margin rate was pressured by mix from limited distribution and rare and orphan therapies.
- +12 more takeaways
Steve Madden Limited Second Quarter 2025 Earnings Call - Tariff Shock Crushes Wholesale While Kurt Geiger Offers Growth
Steve Madden reported a quarter flattened by tariff disruption that drove order cancellations, shipment delays, and margin pressure even as the Kurt Geiger acquisition padded revenue and DTC mix. Cons...
- Tariff disruption was the dominant theme, causing order cancellations, shipment delays, and higher landed costs that pressured revenue and margins in Q2 2025.
- Consolidated revenue was $559.0 million, a 6.8% increase versus Q2 2024, but excluding the Kurt Geiger acquisition, consolidated revenue declined 10% year over year.
- Wholesale revenue fell to $360.6 million, down 6.4% year over year; excluding Kurt Geiger, wholesale declined 12.8%.
- +13 more takeaways
BrightSpring Health Services Q2 2025 Earnings Call - Specialty Pharmacy and LDD Momentum Lift Revenue and Adjusted EBITDA
BrightSpring reported a strong Q2 with broad-based growth, driven primarily by Pharmacy Solutions where specialty and infusion momentum and limited distribution drug (LDD) wins drove top-line and EBIT...
- Total company revenue was $3.1 billion in Q2 2025, up 29% year over year on continuing operations (Community Living reported as discontinued).
- Total company adjusted EBITDA was $143 million in Q2 2025, also up 29% year over year, with a corporate EBITDA margin of 4.5% that was flat versus prior year.
- Management raised 2025 guidance (continuing ops), now expecting total revenue of $12.2 billion to $12.6 billion and total adjusted EBITDA of $590 million to $605 million, up $20 million at both ends from the prior range.
- +14 more takeaways
Insperity Second Quarter 2025 Earnings Call - Benefits-cost pressure trims 2025, Workday HR Scale pitched as the 2026 fix
Insperity reported Q2 EPS of $0.26 and adjusted EBITDA of $32 million, missing the low end of guidance as healthcare costs ran hotter than expected. Unit growth was modestly positive, retention remain...
- Q2 reported EPS was $0.26 and adjusted EBITDA was $32 million, missing the low end of company guidance by $0.03 per share and $1 million respectively.
- Average paid worksite employees rose 0.7% year over year to 309,115, with worksite employees from new sales up 2% versus Q2 2024.
- Client retention averaged 99% per month in Q2, in line with prior year results.
- +14 more takeaways
Fluor Q2 2025 Earnings Call - NuScale Mark-to-Market Boost Masks Execution Strains and Cash Tightening
Fluor reported a $4.0 billion quarter, but the headline GAAP uplift was dominated by a $3.2 billion pre-tax mark-to-market gain on its NuScale stake. Under the surface the business shows familiar engi...
- GAAP headline was skewed by a $3.2 billion pre-tax mark-to-market gain on NuScale, with a related tax impact of $757 million.
- Reported revenue was $4.0 billion in Q2 2025, with consolidated new awards of $1.8 billion, 72% reimbursable.
- Company recognized $1.7 billion of positive backlog adjustments tied to scope changes on reimbursable work, largely in Urban Solutions, which deferred about $13 million of PGM this quarter.
- +16 more takeaways
Urban Edge Properties Q2 2025 Earnings Call - Retail rebound, record occupancy and accretive capital recycling lift guidance
Urban Edge reported a strong Q2, driven by rising occupancy, robust leasing spreads and active capital recycling. FFO as adjusted rose to $0.36 for the quarter, up 12% year over year, and management r...
- FFO as adjusted was $0.36 in Q2, up 12% year over year, and guidance was raised by $0.02 to $1.40 to $1.44 for 2025.
- Same property NOI, including redevelopment, grew 7.4% in the quarter, or 5.6% excluding $1.2 million of nonrecurring tenant billings.
- Portfolio occupancy improved to 96.7%, shop occupancy hit a record 92.5%, and management sees room to push shop occupancy to 93–94%.
- +11 more takeaways
Quaker Houghton Q2 2025 Earnings Call - Asia Pacific Share Gains and Additional $20M Cost Plan Aim to Offset Tariff Headwinds
Quaker Houghton delivered a resilient Q2: $483 million in sales, +4% year-over-year, driven by 2% organic volume growth and a heavy dose of Asia Pacific outperformance. Management leaned into the play...
- Q2 net sales $483 million, up 4% year-over-year.
- Organic volumes increased 2% year-over-year, helped by roughly 5% new business wins; acquisitions contributed ~6% to sales.
- Adjusted EBITDA $75.5 million, adjusted EBITDA margin 15.6%; gross margin 36%, modestly below prior-quarter 36.4% and below near-record 2024 levels.
- +11 more takeaways